ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 891,68
-0,19%
Dow Jones
44 873,28
0,71%
DAX
21 585,93
0,35%
Brent Oil
74,755
0,23%
Bitcoin
97 789,81
1,21%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. FibroGen Inc (FGEN) Cours

FibroGen Inc

FibroGen Inc (FGEN)

Foresight Environmental Infrastructure Limited
0,507
0,0438
(9,46%)
Fermé 06 Février 10:00PM
Retardé de 15 minutes
0,505
-0,002
(-0,39%)
Après les heures de négociation: 1:39AM
Retardé de 15 minutes

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
0,505
Prix Achat
0,501
Prix Vente
0,509
Volume échangé
691 539
0,4501 Fourchette du Jour 0,51
0,18 Plage de 52 semaines 2,93
Cap du marché
50,889M
Clôture Veille
0,4632
Ouverture
0,454
Dernière Transaction
1
@
0.5049
Dernière heure de transaction
Volume financier
US$ 330 117
VWAP
0,477366
Volume moyen (3 m)
1 267 669
Actions en circulation
100 770 153
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,18
Bénéfice par action (BPA)
-2,82
Chiffre d'affairess
147,75M
Bénéfice net
-284,23M

À propos de FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated... FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.fibrogen.com
Siège social
Wilmington, Delaware, USA
Fondé
-
FibroGen Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker FGEN. Le dernier cours de clôture d'FibroGen était de US$0,46. Au cours de la dernière année, les actions de FibroGen ont été négociées dans une fourchette de prix de US$ 0,18 à US$ 2,93.

FibroGen compte actuellement 100 770 153 actions en circulation. La capitalisation boursière d'FibroGen est de US$46,68 million. FibroGen a un ratio cours/bénéfice (ratio PE) de -0.18.

FGEN Dernières nouvelles

Plus de nouvelles

Form 4 - Statement of changes in beneficial ownership of securities

11 Janvier 2025
Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities

18 Décembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

16 Décembre 2024
Edgar (US Regulatory)

FibroGen Appoints David DeLucia as Chief Financial Officer

SAN FRANCISCO, Dec. 16, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced the appointment of David DeLucia to Chief Financial Officer (CFO), effective December 16, 2024. The...

16 Décembre 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

10 Décembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

10 Décembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

10 Décembre 2024
Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

14 Novembre 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

12 Novembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

12 Novembre 2024
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.00510.50.5099990.454823590.47993536CS
4-0.105-17.21311475410.610.69930.459879380.55439742CS
120.104926.21844538870.40010.7550.1812676690.46869388CS
260.09723.77450980390.4080.7550.1812495320.41661238CS
52-1.305-72.09944751381.812.930.1818922011.06539471CS
156-14.015-96.522038567514.5225.690.1817849534.45304553CS
260-45.595-98.904555314546.157.20880.18147059810.59162514CS

FGEN - Frequently Asked Questions (FAQ)

What is the current FibroGen share price?
The current share price of FibroGen is US$ 0,505
How many FibroGen shares are in issue?
FibroGen has 100 770 153 shares in issue
What is the market cap of FibroGen?
The market capitalisation of FibroGen is USD 46,68M
What is the 1 year trading range for FibroGen share price?
FibroGen has traded in the range of US$ 0,18 to US$ 2,93 during the past year
What is the PE ratio of FibroGen?
The price to earnings ratio of FibroGen is -0,18
What is the cash to sales ratio of FibroGen?
The cash to sales ratio of FibroGen is 0,35
What is the reporting currency for FibroGen?
FibroGen reports financial results in USD
What is the latest annual turnover for FibroGen?
The latest annual turnover of FibroGen is USD 147,75M
What is the latest annual profit for FibroGen?
The latest annual profit of FibroGen is USD -284,23M
What is the registered address of FibroGen?
The registered address for FibroGen is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the FibroGen website address?
The website address for FibroGen is www.fibrogen.com
Which industry sector does FibroGen operate in?
FibroGen operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
RFACURF Acquisition Corporation
US$ 10,12
(96,12%)
22,97k
IVVDInvivyd Inc
US$ 2,1001
(68,01%)
79,18M
ASSTAsset Entities Inc
US$ 0,810001
(47,46%)
170,15M
ACBAurora Cannabis Inc
US$ 5,37
(45,92%)
69,87M
RNAZTransCode Therapeutics Inc
US$ 8,885
(44,24%)
17,23M
VLCNVolcon Inc
US$ 1,82
(-43,13%)
3,88M
CSAICloudastructure Inc
US$ 8,12
(-37,44%)
250,67k
CAPTCaptiVision Inc
US$ 0,6819
(-35,06%)
8,88M
LRHCLa Rosa Holdings Corporation
US$ 0,2695
(-31,88%)
4,46M
LYTLytus Technologies Holdings PTV Ltd
US$ 0,416999
(-30,91%)
1,23M
CYNCYNGN Inc
US$ 0,083
(16,90%)
449,48M
NVDANVIDIA Corporation
US$ 124,83
(5,21%)
263,49M
RIMEAlgorhythm Holdings Inc
US$ 0,0206
(-15,57%)
238,29M
ASSTAsset Entities Inc
US$ 0,810001
(47,46%)
170,15M
BHATBlue Hat Interactive Entertainment Technology
US$ 0,051599
(17,81%)
143,98M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
FGEN
FibroGen
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces